Evaxion A (EVAX) Debt to Equity (2021 - 2025)
Evaxion A (EVAX) reported Debt to Equity of $0.32 for Q4 2025, up 106.57% on a YoY basis from $0.16 in Q4 2024, and up 106.57% quarter-over-quarter from -$4.94 in Q4 2024.
Evaxion A (EVAX) Debt to Equity (2021 - 2025) Analysis & Trends
Evaxion A has reported Debt to Equity for 5 years, with the latest figure at $0.32 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity rose 106.57% year-over-year to $0.32; the trailing twelve-month figure through Dec 2025 stood at $0.32 (up 106.57% YoY), and the FY2025 full-year result was $0.32, up 106.57% from the prior year.
- Debt to Equity for Q4 2025 stood at $0.32, up from -$4.94 in the prior quarter.
- The five-year high for Debt to Equity was $1.99 in Q2 2022, with the low at -$4.94 in Q4 2024.
- Historically, Debt to Equity has averaged -$0.22 across 5 years, with a median of $0.32 in 2025.
- Annual changes were most pronounced in 2022 — Debt to Equity soared 2571.22% — and 2023, when it plunged 289.8%.
- Evaxion A's Debt to Equity stood at $0.04 in 2021, then soared by 2571.22% to $0.96 in 2022, then sank by 289.8% to -$1.83 in 2023, then plunged by 170.34% to -$4.94 in 2024, then surged by 106.57% to $0.32 in 2025.
- The last three Debt to Equity figures came in at $0.32 (Q4 2025), -$4.94 (Q4 2024), and -$1.83 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.32 |
| Dec 31, 2024 | -4.94 |
| Dec 31, 2023 | -1.83 |
| Jun 30, 2023 | 1.95 |
| Dec 31, 2022 | 0.96 |
| Jun 30, 2022 | 1.99 |
| Dec 31, 2021 | 0.04 |